Literature DB >> 11798171

Dioxin stimulates synthesis and secretion of IgE-dependent histamine-releasing factor.

Kosuke Oikawa1, Tetsuya Ohbayashi, Junsei Mimura, Yoshiaki Fujii-Kuriyama, Shigetada Teshima, Kazuhito Rokutan, Kiyoshi Mukai, Masahiko Kuroda.   

Abstract

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD; dioxin) is the most toxic man-made member of the class of environmental pollutants represented by polychlorinated dibenzo-p-dioxins and dibenzofurans. TCDD produces a wide variety of toxic effects. However, the downstream genes targeted by TCDD and their relation to the diversity of dioxin toxicity symptoms are poorly understood. To identify the target genes of TCDD, we used a cDNA representational difference analysis (RDA) to compare the mRNA patterns of mouse embryonic stem (ES) cells that had and had not been exposed to TCDD. Here we show that TCDD stimulated the expression of IgE-dependent histamine-releasing factor (HRF) mRNA via an aryl hydrocarbon receptor (AhR)-dependent pathway. TCDD also induced the synthesis and secretion of HRF. To our knowledge, this is the first example of HRF being a direct transcriptional target of a toxic agent. HRF has previously been shown to induce histamine release in a dose-dependent manner, at least in vitro. Thus, our data suggest that "endocrine-disrupting" agents may have the potential to influence allergic disorders in the human body.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11798171     DOI: 10.1006/bbrc.2001.6302

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Upregulation of TCTP expression in human skin squamous cell carcinoma increases tumor cell viability through anti-apoptotic action of the protein.

Authors:  DI Wu; Ze Guo; Wei Min; Bingrong Zhou; Mingna Li; Wei Li; Dan Luo
Journal:  Exp Ther Med       Date:  2011-12-28       Impact factor: 2.447

2.  Translationally controlled tumor protein of Brugia malayi functions as an antioxidant protein.

Authors:  Munirathinam Gnanasekar; Kalyanasundaram Ramaswamy
Journal:  Parasitol Res       Date:  2007-08-09       Impact factor: 2.289

3.  Translationally controlled tumor protein is a novel heat shock protein with chaperone-like activity.

Authors:  Munirathinam Gnanasekar; Gajalakshmi Dakshinamoorthy; Kalyanasundaram Ramaswamy
Journal:  Biochem Biophys Res Commun       Date:  2009-06-10       Impact factor: 3.575

4.  Ligand binding reveals a role for heme in translationally-controlled tumor protein dimerization.

Authors:  Andrew T Lucas; Xiangping Fu; JingJing Liu; Mary K Brannon; Jianhua Yang; Daniel G S Capelluto; Carla V Finkielstein
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

5.  Dimerization of translationally controlled tumor protein is essential for its cytokine-like activity.

Authors:  Miyoung Kim; Hyun Jung Min; Hee Yeon Won; Heejin Park; Ji-Chul Lee; Heung-Woo Park; Junho Chung; Eun Sook Hwang; Kyunglim Lee
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

6.  Beneficial effects of aminoguanidine on skin flap survival in diabetic rats.

Authors:  Ayse Ozturk; Cemal Fırat; Hakan Parlakpınar; Aysun Bay-Karabulut; Hale Kirimlioglu; Ali Gurlek
Journal:  Exp Diabetes Res       Date:  2012-12-13

7.  Sumoylation of human translationally controlled tumor protein is important for its nuclear transport.

Authors:  Gnanasekar Munirathinam; Kalyanasundaram Ramaswamy
Journal:  Biochem Res Int       Date:  2012-04-11

8.  A novel oncogenic pathway by TLS-CHOP involving repression of MDA-7/IL-24 expression.

Authors:  K Oikawa; M Tanaka; S Itoh; M Takanashi; T Ozaki; Y Muragaki; M Kuroda
Journal:  Br J Cancer       Date:  2012-05-15       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.